Table 2.
Association of the baseline BMI with neuroimaging biomarker changes for 2-year
| Estimate | 95% CI | t value | p value | |
|---|---|---|---|---|
| Dependent variable: Aβ deposition | ||||
| Model 1a | ||||
| Baseline BMI x time | 0.000 | -0.003 to 0.002 | -0.359 | .720 |
| Model 2b | ||||
| Baseline BMI x time | 0.000 | -0.003 to 0.002 | -0.426 | .671 |
| Dependent variable: Tau deposition | ||||
| Model 1a | ||||
| Baseline BMI x time | -0.018 | -0.030 to -0.006 | -3.027 | .003 |
| Model 2b | ||||
| Baseline BMI x time | -0.016 | -0.028 to -0.004 | -2.703 | .008 |
Abbreviations: Aβ β-amyloid protein, BMI body mass index, CI confidence interval
aAdjusted for age, sex, APOE4, baseline Aβ or Tau and their interactions with time
bAdjusted for age, sex, APOE4, baseline Aβ a or Tau, vascular risk score, and their interactions with time